<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04655326</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00012299</org_study_id>
    <nct_id>NCT04655326</nct_id>
  </id_info>
  <brief_title>Probiotic Therapy for Children and Adults With Autism Spectrum Disorder</brief_title>
  <official_title>Assessment of Customized Probiotic Therapy for Children and Adults With Autism Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sun Genomics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Arizona State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study of the effect of a customized probiotic on children and adults with autism,&#xD;
      including effects on autism symptoms and gastrointestinal symptoms.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SunGenomics provides its customers with a customized probiotic based on an analysis of the&#xD;
      microbiota in their stool samples. Customers who have autism spectrum disorders are invited&#xD;
      to participate in this study by completing several questionnaires about their medical&#xD;
      history, diet, autism symptoms, and gastrointestinal symptoms before taking the probiotic,&#xD;
      and to repeat those questionnaires approximately 3 months later. This is effectively an&#xD;
      open-label study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">March 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Each participant receives a customized probiotic based on the results of the measurement of their gut microbiota</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Parent Global Impressions of Autism</measure>
    <time_frame>change in score between baseline and 3 months</time_frame>
    <description>questionnaire which assesses 20 different autism-related symptoms on a 7-point scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Social Responsiveness Scale</measure>
    <time_frame>change in score between baseline and 3 months</time_frame>
    <description>A questionnaire about social skills, where higher scores suggest more severe autism. Scores range from 0 to 195, with higher scores indicating more severe problems.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal Symptom Rating Scale</measure>
    <time_frame>change in score between baseline and 3 months</time_frame>
    <description>A questionnaire which evaluates 15 gastrointestinal symptoms on a severity scale from 1 (none) to 7 (severe)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant receives a customized probiotic based on the results of the test of their microbiota</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Flore</intervention_name>
    <description>personalized blend of GRAS approved probiotic strains, prebiotics, and botanicals</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. New client of Sun Genomics (has applied for testing and treatment, but not yet begun&#xD;
             treatment)&#xD;
&#xD;
          2. Diagnosis of ASD (initially based on self-report of ASD diagnosis by appropriate&#xD;
             medical professional, and then verified by an evaluation of the Social Responsiveness&#xD;
             Scale (SRS-2) by ASU staff.&#xD;
&#xD;
          3. Children and adults ages 2.5-75 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Antibiotic use in the last two months (not counting topical antibiotics)&#xD;
&#xD;
          2. Any changes in medications, nutritional supplements, therapies, in the last two&#xD;
             months, or any plans to change them during the first 3 months of probiotic treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Months</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>James B. Adams, PhD</last_name>
    <phone>480 965 3316</phone>
    <email>jim.adams@asu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Devon Coleman, BS</last_name>
    <phone>480 965 5071</phone>
    <email>devon.coleman@asu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Arizona State University</name>
      <address>
        <city>Tempe</city>
        <state>Arizona</state>
        <zip>85287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James B Adams, PhD</last_name>
      <phone>480-965-3316</phone>
      <email>jim.adams@asu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Devon Coleman, BS</last_name>
      <phone>480 965 5071</phone>
      <email>devon.coleman@asu.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://autism.asu.edu/research-studies</url>
    <description>link to official study ad</description>
  </link>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 30, 2020</study_first_submitted>
  <study_first_submitted_qc>November 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2020</study_first_posted>
  <last_update_submitted>November 30, 2020</last_update_submitted>
  <last_update_submitted_qc>November 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Arizona State University</investigator_affiliation>
    <investigator_full_name>James B Adams</investigator_full_name>
    <investigator_title>President's Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

